Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EIPR1, also known as EARP and GARP complex interacting protein 1, is a WD40 repeat-containing scaffolding protein essential for vesicular protein trafficking in eukaryotic cells[1][2][4]. It interacts physically and functionally with the EARP (endosome-associated recycling protein) and GARP (Golgi-associated retrograde protein) complexes, supporting their stability, proper localization, and membrane association[2][1][5]. EIPR1 is crucial for the retention and sorting of cargo proteins, particularly in dense-core vesicles—specialized secretory organelles involved in regulated release of peptide hormones, growth factors, and neuropeptides[1][2][5]. EIPR1 controls the recycling of cargo molecules like the transferrin receptor and is especially important in neurons and neuroendocrine cells, impacting processes such as insulin secretion and locomotion[1][2]. The gene has also been reported as a tumor-suppressor candidate in cancer-prone genomic regions[4].
Not applicable (No drugs reported to target EIPR1 directly, so there are no mechanisms of action listed in literature.)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EARP and GARP complex interacting protein 1 (EIPR1).